Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at SVB Leerink LLC from $36.00 to $41.00. They now have a "market perform" rating

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com